Dexmedetomidine in rhinoplasty

Phase 3

• Conditions: Pain after septorhinoplasty.; Other acute postprocedural pain; G89.18

• Registration Number: IRCT20211225053519N3
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Elective Septorhinoplasty operation

Exclusion Criteria

Coagulation disorder
Cardiac disorder
Kidney disorder
Liver disorder
Consuming opioids in last two month

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: 12 and 24 hours after the operation. Method of measurement: VAS questionnaire.;Agitation. Timepoint: 12 and 24 hours after the operation. Method of measurement: RASS questionnaire.;Postoperative bleeding. Timepoint: 24 hours after the operation. Method of measurement: Number of dressing in first 24 hours.;Patient satisfaction. Timepoint: During discharge. Method of measurement: ROE questionnaire.